Error: Could not add to watchlist. X

Conatus Pharmaceuticals Inc

+ Watchlist
CNAT:US
NASDAQ GM
3.68
USD
0.15
4.25%
As of 20:10:00 ET on 08/27/2015.
Open
3.60
Day Range
3.46 - 3.77
Volume
127,659
Previous Close
3.53
52Wk Range
3.44 - 11.74
1 Yr Return
-45.32%
Open
3.60
Day Range
3.46 - 3.77
Volume
127,659
Previous Close
3.53
52Wk Range
3.44 - 11.74
1 Yr Return
-45.32%
YTD Return
-47.43%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.45
Market Cap (m USD)
72.565
Shares Outstanding (m)
19.719
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Conatus Pharmaceuticals, Inc. develops therapeutics to treat liver disease. The Company offers drugs to control programmed cell death that contributes to a range of liver diseases and cancer treatments. Conatus Pharmaceuticals provides its products in the United States.
ADDRESS
16745 West Bernardo Drive
Suite 200
San Diego, CA 92127
United States
PHONE
1-858-376-2600
  • Steven J Mento
    President/CEO/Co-Founder
  • David T Hagerty
    Exec VP:Clinical Development
  • Alfred P Spada
    Exec VP:R & D/Chief Scientific Ofcr
  • Charles J Cashion
    Senior VP:Finance/CFO/Secy
Show More